One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registryLeslie R. Harrold, Mohamed Yassine|Arthritis Research & Therapy|2018Cited by 39
AB0286 A Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-To-Target Approach in the Clinical Care of Rheumatoid Arthritis PatientsLeslie R. Harrold, Joel M. Kremer, J. Timothy Harrington et al.|Annals of the Rheumatic Diseases|2015Cited by 5